SIGN UP
LOG IN
U
UNCY
Unicycive Therapeutics Inc
0.64
0.000.00%After Hours: 0.6330 -0.01 -1.09%19:33 04/25 EDT
OPEN/PREV CLOSE0.6370/0.6400
TODAY RANGE0.6323-0.6499
VOL229.27K
MARKET CAP76.61M
52 WEEK RANGE0.2020-1.289
AVG VOL (3M)965.04K
% TURNOVER0.19%
TURNOVER--
P/E (TTM)-1.1333
% RANGE2.75%
EPS(TTM)-0.5647
P/E(FORWARD)-2.0000
P/B9.80
BVPS0.0653
DIVIDEND--
P/S32.99
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP72.54M
SHARES OUTSTANDING119.71M
NEXT EARNINGS--
FREE FLOAT113.35M
LOT SIZE1
EX-DIV DATE--
News
Press Releases
Financial Reports
Profile
TipRanks·4d ago
Unicycive Therapeutics initiated with a Buy at Guggenheim
TipRanks·04/01 13:16
Noble Financial Sticks to Their Buy Rating for Unicycive Therapeutics (UNCY)
TipRanks·04/01 10:26
Unicycive Therapeutics price target raised to $7.50 from $4 at H.C. Wainwright
Reuters·04/01 06:50
U.S. RESEARCH ROUNDUP-AIG, Corcept Therapeutics, Dow
Seeking Alpha·03/31 17:22
Unicycive Therapeutics GAAP EPS of -$0.56
Press release·03/31 14:22
UNITED STATES SECURITIES AND EXCHANGE COMMISSION FORM 10-K
Same Industry
Name/Symbol
Change%
Price
Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
① During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit: https://www.webull.hk/pricing
② More than 40M Downloads Globally : data based on Webull Technologies Limited's internal statistics as of July 14, 2023.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
① During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit: https://www.webull.hk/pricing
② More than 40M Downloads Globally : data based on Webull Technologies Limited's internal statistics as of July 14, 2023.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2025 Webull Securities Limited. All rights reserved.